Methylated ARHGAP40 DNA as a potential biomarker for early diagnosis in high-grade ovarian serous cancer
Abstract Ovarian cancer ranks as the eighth most common malignancy in women globally. Early detection remains a critical challenge for improving ovarian cancer diagnosis and treatment outcomes. Our prior study demonstrated that ARHGAP40 downregulation in basal cell carcinoma is attributed to CpG isl...
Saved in:
| Main Authors: | Jiaxin Chai, Dongni Leng, Shuwei Guo, Rusong Zhang, Jiandong Wang, Yun Gu, Qiu Rao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Ovarian Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13048-025-01729-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Bridge Capture technology for mutation profiling in liquid biopsies of metastatic colorectal cancer patients
by: Aparna Ganesan, et al.
Published: (2025-07-01) -
Clinical Utility of ctDNA Analysis in Lung Cancer—A Review
by: Kamil Makar, et al.
Published: (2025-06-01) -
Imaging and outcome correlates of ctDNA methylation markers in prostate cancer: a comparative, cross-sectional [⁶⁸Ga]Ga-PSMA-11 PET/CT study
by: Kilian Kluge, et al.
Published: (2025-02-01) -
Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring
by: Alessandro Mannucci, et al.
Published: (2024-11-01) -
Advancing diagnosis and early risk assessment of preeclampsia through noninvasive cell-free DNA methylation profiling
by: Machteld Baetens, et al.
Published: (2024-12-01)